A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
As many as half of obsessive-compulsive disorder (OCD) patients treated with an adequate trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment and continue to exhibit significant symptoms. Many studies have assessed the effectiveness of antipsychotic augmentation in SRI-refractory OCD. In this systematic review, we evaluate the efficacy of antipsychotic augmentation in treatment-refractory OCD. The electronic databases of PubMed, PsychINFO (1967-2005), Embase (1974-2000) and the Cochrane Central Register of Controlled Trials (CENTRAL, as of 2005, Issue 3) were searched for relevant double-blind trials using keywords 'antipsychotic agents' or 'neuroleptics' and 'obsessive-compulsive disorder'. Search results and analysis were limited to double-blind, randomized control trials involving the adult population. The proportion of subjects designated as treatment responders was defined by a greater than 35% reduction in Yale Brown Obsessive-Compulsive Scale (Y-BOCS) rating during the course of augmentation therapy. Nine studies involving 278 participants were included in the analysis. The meta-analysis of these studies demonstrated a significant absolute risk difference (ARD) in favor of antipsychotic augmentation of 0.22 (95% confidence interval (CI): 0.13, 0.31). The subgroup of OCD patients with comorbid tics have a particularly beneficial response to this intervention, ARD=0.43 (95% CI: 0.19, 0.68). There was also evidence suggesting OCD patients should be treated with at least 3 months of maximal-tolerated therapy of an SRI before initiating antipsychotic augmentation owing to the high rate of treatment response to continued SRI monotherapy (25.6%). Antipsychotic augmentation in SRI-refractory OCD is indicated in patients who have been treated for at least 3 months of maximal-tolerated therapy of an SRI. Unfortunately, only one-third of treatment-refractory OCD patients show a meaningful treatment response to antipsychotic augmentation. There is sufficient evidence in the published literature, demonstrating the efficacy of haloperidol and risperidone, and evidence regarding the efficacy of quetiapine and olanzapine is inconclusive. Patients with comorbid tics are likely to have a differential benefit to antipsychotic augmentation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are some case reports that methylphenidate can worsen OCD symptoms [174] and for some patients antipsychotic medications that reduce dopamine levels are effective [175] (Table 3).”
From Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder (2021) · cites this paper as [175]
In the citing paper
“A meta-analysis of the adult literature examining the use of antipsychotic augmentation in the treatment of OCD showed that the NNT for OCD and tics was 2.3 compared to 5.9 for those with OCD alone.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [139]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
(1996) · Cited by 6,884
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,351
A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
Skoog, G., & Skoog, I. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.121 · Cited by 632
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
The International Journal of Neuropsychopharmacology
Lerer, B., Frazer, A., Stahl, S., Farde, L., & Lesch, P. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798009018 · Cited by 501
The Epidemiology and Differential Diagnosis of Obsessive-Compulsive Disorder
Rasmussen, S. A., & Eisen, J. L. (1992) · Zwangsstörungen / Obsessive-Compulsive Disorders · doi:10.1007/978-3-642-77608-3_1 · Cited by 493
Research works printed but not linked: 2
- Muller C . Vorlaufige Mitteilung zur langen Katamnese der Zwangskranken. Nervenartz 1953; 24: 112–115.
- Rennie TAC . Prognosis in the Psychoneurosis: Benign and Malignant Developments, Current Problems in Psychiatric Diagnosis. New York: Grune & Stratton Inc, 1953.
Cited by
Items 501–600 of 638
Uğuz, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_16 · Cited by 1
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_58 · Cited by 1
An overview of the pharmacological options for pediatric obsessive-compulsive disorder
Marazziti, D., & Pozza, A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2142779 · Cited by 2
“based augmentation strategy for resistant OCD is adding a low-dose of an atypical antipsychotic medication to an SSRI [45,46].”
BackgroundNeurochemistry of Childhood Anxiety Disorders
Havel, L. K., Mehta, P., Gautam, A., Danielyan, E., & Saxena, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-14080-8_5 · Cited by 2
Oh, S., Cho, S., Moon, S., Lee, J., Kim, M., Lee, T. Y., & Kwon, J. S. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103847 · Cited by 1
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I
Cortese, S., Besag, F., Clark, B., Hollis, C. P., Kilgariff, J., Moreno, C., Nicholls, D., Wilkinson, P. O., Woodbury‐Smith, M., & Sharma, A. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241239582 · Cited by 3
“The evidence suggests that low-dose antipsychotic augmentation benefits around one-third of adult patients with OCD (Bloch, 2006).”
BackgroundInfluentialNeurodevelopmental Disorders: Stereotypical Movement Disorders and Tic Disorders
Vitulano, L. A., Vitulano, M. L., King, R. A., Yazgan, M. Y., & Leckman, J. F. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_45 · Cited by 1
Self-citationPsychopharmacology for Pediatric OCD and Related Disorders
Greenberg, E., Johnson, G., & GELLER, D. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_10 · Cited by 1
Farhat, L. C., & Bloch, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00239-6 · Cited by 1
Self-citationEggers, C., & Döpfner, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19846-5_18 · Cited by 1
Tic-Related Obsessive-Compulsive Disorder
Olatunji, B. O., Wilhelm, S., & Deckersbach, T. (2007) · Elsevier eBooks · doi:10.1016/b978-008044701-8/50007-3 · Cited by 1
The Treatment of Obsessive-Compulsive Disorder and the Approaches to Treatment Resistance
Pallanti, S., Grassi, G., & Cantisani, A. (2011) · InTech eBooks · doi:10.5772/21517 · Cited by 3
Simpson, H. B., & Harrison-Read, P. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.037 · Cited by 1
Trastornos de ansiedad y trastorno obsesivo-compulsivo
Garca-Paraju, P., & Lpez, M. M. (2007) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(07)74670-2 · Cited by 1
Savaş, E., Özovacı, A., Kokaçya, M. H., Altındağ, A., & Vırıt, O. (2010) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2010.11790677 · Cited by 1
Gap between recommended and actual practice in pediatric obsessive–compulsive disorder
Ale, C. M., & Storch, E. A. (2012) · Clinical Practice · doi:10.2217/cpr.12.8 · Cited by 1
Verhaltenstherapie und Psychopharmaka
Zurowski, B., & Hohagen, F. (2009) · Springer eBooks · doi:10.1007/978-3-540-79541-4_19 · Cited by 2
Neurobiologie der Zwangsstörung: Teil 1: Konzepte zur Pathophysiologie und Genetik
Hohagen, F., Kordon, A., & Zurowski, B. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1628687 · Cited by 3
Costa, D. L. D. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05122016-164417 · Cited by 2
Obsessive-Compulsive Disorders in Childhood
Leckman, J. F., & Bloch, M. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_124 · Cited by 1
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P. R., Kjernisted, K. D., & Ameringen, M. V. (2023) · doi:10.32920/14638581.v1 · Cited by 1
Kombinationen von Psychopharmaka
Messer, T., Tiltscher, C., & Schmauß, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_11 · Cited by 1
Roessner, V., Mehler‐Wex, C., & Warnke, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-79275-9_28
Poyurovsky, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511686931.010
Obsessive–Compulsive and Related Disorders: Obsessive–Compulsive Disorder and Hoarding Disorder
Pato, M. T., Steketee, G. S., Eisen, J. L., Yip, A. G., & Phillips, K. A. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch57
Castaldelli-Maia, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.27044-x
de Alvarenga, P. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-04082014-084337 · Cited by 1
Untersuchungen zur Monozyten-Stimulierbarkeit bei Tourette-Syndrom
Wildenauer, A. (2011) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.13711
Darstellung pathophysiologisch und therapeutisch relevanter Hirnareale psychiatrischer Erkrankungen
Shababi-Klein, J. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14298 · Cited by 1
Il trattamento del disturbo ossessivo-compulsivo resistente
Aguglia, A., Albert, U., Cori, D. D., Maina, G., & Bogetto, F. (2011) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2010.12.003
Katerberg, H., & den Boer, H. (2010) · Neuropraxis · doi:10.1007/s12474-010-0007-0
Carey, P. D. (2008) · SUNScholar (Stellenbosch University)
Ducasse, D. (2013) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.s10-001
“However, the therapeutic effectiveness of SSRIs is incomplete, with a response-rate of only 40 to 60% [4].”
Background- Self-citation
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010 · Cited by 1
Aghukwa, N. C. (2015) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.164359
[Therapeutic strategies for obsessive-compulsive disorder refractory to treatment].
Mussa, A. (2008) · PubMed · Cited by 1
Tic Disorder Following Aripiprazole Therapy
Meral, H., ÖZCAN, T. A., ALTINBAŞ, K., ULUKÖK, M. D., & ÖZER, F. (2013) · Journal of Parkinson’s Disease and Movement Disorders · doi:10.5606/phhb.dergisi.2013.04
“[1,2,4,8-10] Hastanın eşzamanlı kullanmış olduğu sertralininde dopamin gerialımını kısmen bloke ediyor olması bu etkinin potansiyelize olmasına neden olmuş olabilir.”
The Use of Antipsychotics in the Treatment of Obsessive-Compulsive Disorder
Walsh, K. H., Scott, E. L., & McDougle, C. J. (2008) · Psychopharm Review · doi:10.1097/01.idt.0000314887.61319.fa
“*Data regarding Y-BOCS response rate from Bloch et al.(39) Mean final dose not reported.”
MethodInfluentialÇocukluk Çaği Başlangiçli Obsesif Kompulsif Bozukluk Childhood-Onset
Karaman, D., & Erdem, M. (2011)
Évolution des symptômes anxieux lors des épisodes thymiques et de leur traitement
Groulier, M. (2016) · HAL · Cited by 1
Obsessive–compulsive disorder and Gilles de la Tourette syndrome
Woehrle, N. S., & Dulawa, S. C. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.016
Medication Treatment of Anxiety Disorders
(2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343664_0012
Voderholzer, U., & Hohagen, F. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50016-2
Sockalingam, S., & Zemans, M. (2007) · Cited by 1
Neural Circuitry in Obsessive Compulsive Disorder: an fMRI Study of the Effect of IV Citalopram
Bhikram, T. (2012) · TSpace (University of Toronto) · Cited by 1
Obsessive-Compulsive Disorder: Overview and Standard Treatment Strategies
Seibell, P. J., Hamblin, R. J., & Hollander, E. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150602-04 · Cited by 1
Leckman, J. F., & Bloch, M. H. (2007) · Elsevier eBooks · doi:10.1016/b978-012369509-3.50027-5
Self-citationTROUBLES OBSESSIONNELS COMPULSIFS CHEZ L'ENFANT ET L'ADOLESCENT
de Alvarenga, P. G. (2012)
Muse, M. D., & Stahl, S. M. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch6 · Cited by 1
Paiva, R. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-27102017-103707
The Use of Quetiapine for Comorbid Bipolar and Obsessive Compulsive Disorders
Yoldi‐Negrete, M., Flores‐Ramos, M., Rodríguez‐Ramírez, A. M., Carvajal-Lohr, A., Ávila-Solorio, J., Alejandra, M.-M. M., Alejandra, A., & González-Flores, L. (2015) · Current Psychopharmacologye · doi:10.2174/2211556005666151216224828
Rubio, C. R. G. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.136274 · Cited by 1
Managing a Child With OCD Who Is Treatment Refractory
Bloch, M. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811427-8.00017-4
Self-citationObsessive–Compulsive Anxiety Disorders
Fineberg, N. A., & Padhi, A. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_323-2
A Complex Case of Obsessive-Compulsive Disorder (OCD)
Drummond, L. M., & Roney, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70311-4_4
The Use of Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)
Dell’Osso, B. M., Benatti, B., & Arici, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-91557-9_16
A system for the visual detection and analysis of obsessive compulsive disorder
Cameron, C. (2018) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27588936
Tourette’s and Other Tic Disorders
Cavanna, A. E. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.028
Drug Augmentation Strategies for Treatment-Resistant Obsessive-Compulsive and Related Disorders
Shavitt, R. G., & Diniz, J. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.019
Stovezky, Y. R., Gershkovich, M., Kayser, R. R., & Simpson, H. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.020
Antipsychotika der zweiten Generation bei der Behandlung von Zwangserkrankungen
Meyer, M. (2018) · mediaTUM (Technical University of Munich)
Third Generation Antipsychotic as add-on therapy inIntractable Obsessive-Compulsive Disorder
Shafti, S. S. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.17.003016
Multidimensional Approaches for A Case of Severe Adult Obsessive - Compulsive Disorder.
Shi, Z., Mei, X., Zhu, Y., Shuai, Y., Chen, Y.-P., Wu, Y., & Shen, Y. (2017) · PubMed Central · doi:10.11919/j.issn.1002-0829.217019 · Cited by 1
“[11] Recently, Markus et al meta-analyzed 14 doubleblind randomized controlled trials, and confirmed antipsychotic augmentation of SSRIs in treatmentresistant OCD patients.”
BackgroundRaichandani, O. P., & Chaturvedi, J. N. (2019) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20193196
Eating disorders and compulsivity: neural, computational, and psychopharmacological approaches
Pike, A. C. (2018) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-o5rzdvay1 · Cited by 1
The Sapap3-knockout mouse model manifests a spectrum of repetitive behavioursPreprint
Lamothe, H., Schreiweis, C., Mallet, L., & Burguière, E. (2021) · HAL · doi:10.1101/2020.01.22.915215 · Cited by 1
Paliperidone in Obsessive-Compulsive Disorder
Panthee, P., & Morgado, P. F. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001181
The neurocognitive correlates of compulsivity
Seow, X. F. T. (2020) · Arrow@dit (Dublin Institute of Technology)
Obsessive-Compulsive and Related Disorders in Transitional-Age Youth
Okereke, N. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-62113-1_9
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.790
Obsessive-Compulsive Anxiety Disorders in Childhood
Leckman, J. F., & Bloch, M. H. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_124-2
Self-citationChen, C. (2016) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2016.21.1.6
Obsessive-Compulsive Anxiety Disorders in Childhood
Bloch, M. H., & Leckman, J. F. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_124
Self-citationOCD, Anxiety Disorders, and PTSD
D’Urso, G., & da Silva, R. D. M. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-76136-3_25
Kombinationen mit Psychopharmaka in der Behandlung von Angst- und Zwangsstörungen
Volz, H. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_8
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as06
Simonyan, K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725377695.793555300
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372300.as06
Verhaltenstherapie und Psychopharmaka
Zurowski, B., & Hohagen, F. (2018) · Springer eBooks · doi:10.1007/978-3-662-54911-7_16
Obsessive-Compulsive Anxiety Disorders
Fineberg, N. A., & Padhi, A. K. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_323
Treatment of Psychiatric Comorbidities in Tourette Syndrome
Cardona, F., & Rizzo, R. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197543214.003.0027
Neurodevelopmental Disorders: Stereotypical Movement Disorders and Tic Disorders
Vitulano, L. A., Vitulano, M. L., King, R. A., Yazgan, M. Y., & Leckman, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_45-1
Self-citationRoessner, V., & Rothenberger, A. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_26
Le rôle des interneurones à parvalbumine striataux dans la prise de décision perceptuelle
Lavielle, O. (2022) · theses.fr (ABES) · doi:10.70675/a42a0e59z676bz4f79z9905z5839ce85f0ce
Obsessive-Compulsive and Related Disorders
Drummond, L. M., Enara, A., Cirnigliaro, G., Burkauskas, J., & Fineberg, N. A. (2024) · Cambridge University Press eBooks · doi:10.1017/9781911623861.017
Disruption of Consciousness Depends on Insight in OCD and on Positive Symptoms in Schizophrenia
Tümkaya, S., Yücens, B., Gündüz, M., Maheu, M., & Berkovitch, L. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.02.830
Anksiyete ve Travmatik Stres Bozuklukları
Gül, V. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3184 · Cited by 1
Behandlung bei psychischer und körperlicher Komorbidität
Voderholzer, U., Rubart, A., Kathmann, N., Staniloiu, A., Kordon, A., & Zurowski, B. (2024) · Springer eBooks · doi:10.1007/978-3-662-67878-7_11
Pato, M. T., Arnold, P. D., Zohar, J., Bitan, S., Klein, K. P., & Eisen, J. L. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_23 · Cited by 2
Examination of vitamin D status in individuals with obsessive-compulsive disorder
Dahal, T., & Abraham, J. (2024) · Indian Journal of Clinical Anatomy and Physiology · doi:10.18231/j.ijcap.2024.035
Metadata
- Authors
- Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F.
- Affiliations
- Yale University (US)
- Connecticut Mental Health Center (US)
- Corresponding author
- Bloch, M H
- Venue
- Molecular Psychiatry
- Published
- 2006-04-04
- Volume
- 11
- Issue
- 7
- Pages
- 622-632
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2100202859
- Cited by
- 635
- References
- 50
- Citations by year
- 2026: 24 · 2025: 21 · 2024: 22 · 2023: 14 · 2022: 18 · 2021: 25 · 2020: 21 · 2019: 29 · 2018: 34 · 2017: 37 · 2016: 30 · 2015: 53 · 2014: 48 · 2013: 39 · 2012: 39
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-07-26)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tourette Association of America
- National Institutes of Health
- U.S. Public Health Service
- National Institute of Mental Health
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- obsessive-compulsive disorder, treatment-refractory OCD, antipsychotic augmentation, serotonin reuptake inhibitors, haloperidol, risperidone, quetiapine, olanzapine, treatment response, Yale-Brown Obsessive Compulsive Scale
- MeSH terms
- Quetiapine Fumarate, Olanzapine, Adult, Aged, Basal Ganglia Diseases, Benzodiazepines, Depressive Disorder, Dibenzothiazepines, Double-Blind Method, Drug Resistance, Drug Therapy, Combination, Haloperidol, Humans, Middle Aged, Obsessive-Compulsive Disorder, Patient Dropouts, Tic Disorders, Antipsychotic Agents, Comorbidity, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.